西药试题库及答案

西药（共1000题

1000分）一、A1/A2型题、A1/A2型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。(990分)MACROBUTTONDoFieldClick[修改]MACROBUTTONDoFieldClick[删除]（）1、脂溶性药物从胃肠道吸收，主要是通过MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.主动转运吸收B.简单扩散吸收C.易化扩散吸收D.通过离子通道吸收E.胞饮方式吸收（）2、葡萄糖酸钙对该药物的肠道吸收影响最大的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.异烟肼B.氯霉素C.氨苄西林D.四环素E.阿莫西林（）3、牛源性药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.胞磷胆碱B.人胰岛素C.甲睾酮D.琥珀酰明胶注射液（佳乐施，血定安）E.生长激素（）4、钙拮抗药的基本作用是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.阻止钙离子的重吸收B.降低钙离子的血浆蛋白结合率C.阻止钙离子从细胞内外流D.阻止钙离子从体液向细胞内转移E.与钙离子络合使之失去作用（）5、有关沙利度胺描述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.有致畸作用B.蛋白结合率低C.在机体各组织分布广泛D.水溶性低，在水中不稳定E.口服生物利用度低（）6、属于靶向抗肿瘤药的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.吉西他滨B.埃罗替尼C.伊立替康D.多西他赛E.紫杉醇（）7、下列描述加替沙星的特点正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.有严重的光敏副反应B.儿童可以应用C.易导致肾脏毒性D.与其他喹诺酮类抗生素无交叉耐药性E.抗菌活性低于氧氟沙星（）8、对雌激素受体起选择性抑制的药物为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.伊马替尼B.长春碱C.他莫昔芬D.门冬酰胺酶E.多柔比星（）9、可作为抑制胃酸分泌过多的首选药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.解热镇痛药B.非甾体抗炎药C.质子泵抑制药D.胃肠动力药E.硫脲类（）10、下列有关烟酸的描述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.属于B族维生素B.在体内迅速转化成烟酰胺C.口服15～20min达峰浓度D.半衰期约为90minE.具有线性动力学特性（）11、符合线性药物动力学特征的药物，其生物半衰期的1个重要特点是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.取决于开始浓度B.主要取决于首次剂量C.取决于给药途径D.与开始浓度、首次剂量、给药途径均无关E.与开始浓度、首次剂量、给药途径均有关（）12、由于大量输入生理盐水可引起的反应是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.低钠和碱中毒B.低钠和酸中毒C.氯离子负荷增高和酸中毒D.乳酸负荷增加E.高氯和低钠（）13、普鲁本辛（溴丙胺太林）禁用于MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.肝损害者B.心衰竭患者C.青光眼患者D.溃疡病患者E.肠痉挛患者（）14、癌症患者使用止痛药原则正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.癌症患者使用止痛药可不受任何限制B.癌痛药可以突然停药C.哌替啶可用于慢性癌痛的长期止痛D.阿片类药物用于癌痛治疗不受常用剂量限制E.非甾体抗炎药与阿片类药物可轮流替代应用（）15、托品类生物碱中枢作用相对较轻的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.阿托品B.山莨菪碱C.莨菪碱D.樟柳碱E.东莨菪碱（）16、需要载体的转运方式是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.滤过B.主动转运C.简单扩散D.膜孔转运E.胞吐（）17、属于第三代口服头孢菌素MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.头孢氨苄B.头孢呋辛酯C.头孢妥仑匹酯D.头孢克洛E.头孢孟多（）18、咽部念珠菌病可选用MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.链霉素B.两性霉素BC.阿莫西林D.红霉素E.克霉唑（）19、属于紫杉醇剂量限制性毒性MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.皮肤不良反应B.胃肠道反应C.心脏损害D.血管系统不良反应E.骨髓抑制（）20、有关血浆半衰期的描述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.与血药浓度的高低正相关B.随血药浓度的下降而延长C.在一定剂量范围内固定不变，与血药浓度高低无关D.在任何剂量下，固定不变E.与首次服用的剂量成正相关（）21、那格列奈治疗2型糖尿病的机制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.直接分解葡萄糖B.促进胰岛素分泌C.增加机体脏器和组织对胰岛素的敏感性D.加强外周组织对葡萄糖的摄取E.抑制小肠葡萄糖的吸收（）22、特拉唑嗪的降压作用机制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.选择性激动β受体B.阻断α受体C.激动α受体D.选择性阻断α受体E.直接扩张血管（）23、肾功能不良但肝功能尚正常的患者可以应用的抗感染药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.庆大霉素B.妥布霉素C.链霉素D.头孢哌酮E.西索米星（）24、用于治疗慢性粒细胞白血病的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.氟尿嘧啶B.伊马替尼C.沙利度胺D.丝裂霉素E.他莫昔芬（）25、不属于溶血栓药的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.纤溶酶原激活物tPAB.尿激酶C.蛇毒抗凝酶D.肝素E.链激酶（）26、影响氟喹诺酮类抗生素起效时间的药动学参数是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.药时曲线下面积B.血浆半衰期C.肾清除率D.表观分布容积E.达峰时间（）27、下列药物可首选缓解中度癌痛的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.二氢埃托啡片B.盐酸曲马朵缓释片C.酒石酸二氢可待因控释片D.硫酸吗啡控释片E.芬太尼透皮贴剂（）28、下列药物可首选缓解重度癌痛的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.吲哚美辛（消炎痛）控释片B.盐酸曲马朵缓释片C.芬太尼透皮贴剂D.硫酸吗啡控释片E.盐酸哌替啶注射液（）29、目前不再使用的治疗三叉神经痛的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.苯妥英钠B.卡马西平C.γ-氨基丁酸D.氯苯甘醚E.酒精（）30、庆大霉素不适宜治疗的感染是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.变形杆菌感染B.铜绿假单胞菌感染C.链球菌感染D.淋球菌感染E.幽门螺杆菌感染（）31、通过活性代谢物发挥降血压作用的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.氯沙坦B.伊普沙坦C.伊贝沙坦D.替米沙坦E.缬沙坦（）32、可参与抗结核治疗联合用药的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.舒他西林B.舒巴坦C.克拉维酸D.甲氧苄啶E.氧氟沙星（）33、ACEI除降血压外还可用于MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.凝血功能异常B.心绞痛C.糖尿病D.银屑病E.充血性心衰（）34、属于H受体阻断药的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.昂丹司琼B.西替利嗪C.法尼替丁D.西咪替丁E.奥美拉唑（）35、与头孢呋辛属于同一代抗生素的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.头孢噻吩B.头孢哌酮C.头孢孟多D.头孢氨苄E.头孢曲松（）36、属新一代的喹诺酮类药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.氧氟沙星B.左氟沙星C.加替沙星D.培氟沙星E.依诺沙星（）37、阿米巴肝脓肿的首选药物为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.喹宁B.甲硝唑C.土霉素D.依米丁E.乙酰胂胺（滴维净）（）38、氟喹诺酮类药物中安全性相对最好的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.依诺沙星B.莫西沙星C.左氧氟沙星D.司帕沙星E.环丙沙星（）39、属于阿片受体激动药的镇痛药是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.依托度酸B.氨基葡萄糖C.羟考酮D.舒林酸E.氯诺昔康（）40、伊立替康抗肿瘤作用主要通过抑制MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.碱性磷酸酶B.二氢叶酸还原酶C.HMG-CoA还原酶D.拓扑异构酶E.腺苷脱氧酶（）41、较易引起儿童血尿的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.头孢氨苄B.头孢他啶C.头孢哌酮D.头孢曲松E.头孢拉定（）42、下列药物建议孕妇怀孕早期补充用以预防胎儿神经管畸形发生的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.铁剂B.叶酸C.C族维生素D.A族维生素E.钙剂（）43、下列属于西布曲明治疗肥胖症的机制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.抑制5-羟色胺及去甲肾上腺素的再摄取B.引起单胺神经递质释放C.抑制单胺氧化酶的活性D.抑制脂肪从胃肠道吸收E.激动β肾上腺素受体提高能量代谢及产热反应（）44、下列描述苯唑西林性质和作用的说法最确切的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.本品有耐酶性能，适用于产生青霉素酶的细菌所引起的感染B.细菌对青霉素耐药后可选用本品C.本品对细菌产生的青霉素酶有抑制作用D.本品适用于一切耐青霉素的葡萄球菌所致的各种感染E.本品适用于葡萄球菌产酶株所致的周围感染（）45、属于抗躁狂药的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.地西泮B.丙米嗪C.氯扎美酮D.丁螺环酮E.碳酸锂（）46、有关罗哌卡因叙述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.本品为酯类局麻药B.本品为酰胺类局麻药C.对普鲁卡因过敏者禁用本品D.本品的特点是作用时间短E.本品主要经细胞色素P酶代谢（）47、可用于血浆代用品的溶液是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.生理盐水B.葡萄糖注射液C.乳酸钠林格液D.羟乙基淀粉E.高渗盐水（）48、大多数药物吸收的机制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.主动转运吸收B.水溶扩散吸收C.易化扩散吸收D.简单扩散吸收E.膜动转运吸收（）49、临床应用时常用来缓解顺铂肾毒性的方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.加用昂丹司琼B.水化和利尿C.调节酸碱度D.延长给药时间E.增加给药频率（）50、癌症术前化疗的意义正确的说法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.直接杀伤肿瘤细胞或诱导肿瘤细胞凋亡B.降低肿瘤复发率C.进行新抗肿瘤药的临床研究D.防止肿瘤扩散E.提高患者对手术的耐受力（）51、通过活性代谢物发挥降压作用的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.依那普利B.赖诺普利C.卡托普利D.吲达帕胺E.氢氯噻嗪（）52、与青霉素V抗菌谱最近似的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.阿莫西林B.阿帕西林C.美洛西林D.苯唑西林E.青霉素G（）53、使用栓剂时方法不正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.不去掉外面铝箔或包装B.塞栓时注意戴卫生指套C.左侧卧位并弯曲右膝D.将栓剂尖端朝前插入E.尽量在给药后1小时内不排大便（）54、根据对费用和结果以钱数（货币）进行的测量和评估，计算和比较钱数得失净值或费用与效益比值的经济学分析方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.最小成本分析法B.成本效果分析法C.成本费用分析法D.成本效益分析法E.最小二乘法（）55、不具有双硫仑样反应的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.地西泮B.呋喃唑酮C.奥硝唑D.伏立康唑E.酮康唑（）56、可进行新药，临床试验基地的单位必须具备的条件是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.具有药物临床试验资格的机构B.三级甲等医院C.可以自行选定医院D.省级以上的医院E.综合性医院（）57、合用后可使左旋多巴作用加强而不良反应减少的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.卡比多巴B.维生素CC.利血平D.异烟肼E.丙胺太林（）58、目前我国化学药新药在新药审评中分成MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.3类B.5类C.10类D.6类E.8类（）59、贲昔洛韦属于核苷类抗疱疹病毒药，其前体药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.齐多夫定B.泛昔洛韦C.更昔洛韦D.金刚烷胺E.干扰素（）60、需整片吞服的制剂是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.薄膜衣片B.渗透泵型控释片C.所有异形片D.糖包衣片E.小剂量片剂（）61、氨基糖苷类药物不宜静脉注射的主要原因是为了防止MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.过敏性休克B.神经肌肉阻滞反应C.出血D.发生口麻和呃逆反应E.四肢麻痹（）62、复方对乙酰氨基酚片的正常情况下的外观性状为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.淡绿色片，味微酸B.深红色片C.橙黄色片，味微苦D.白色片，味微酸E.绿色，味甘（）63、属于"瘦肉精"主要成分的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.妈富隆（去氧孕烯）B.克仑特罗C.多西环素D.泼尼松E.地塞米松（）64、新药Ⅰ期临床耐受性试验的受试者应该是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.女性志愿者B.男性志愿者C.男、女比例随机的健康志愿者D.所有愿意参加的健康志愿者E.患有新药适应证疾病的患者志愿者（）65、患者使用气雾剂时，正确的操作方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.深吸气的同时揿下按钮→屏气→漱口B.深呼气→吸揿同步吸气→屏气→漱口C.深呼气→吸揿同步→深而长吸气→漱口D.深呼气→揿下按钮→深而长吸气→漱口E.揿下按钮→深而长吸气→屏气→漱口（）66、需要对茶碱类药物进行血药浓度监测主要是因为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.生物利用度低B.给常规剂量，但血药浓度差异较大，治疗窗窄C.不同个体半衰期不定D.有效血药浓度范围大E.动力学呈线性特征（）67、关于新药临床试验的叙述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.试验因为样本数有限而存在一定的局限性B.做过临床试验后可不做上市后评价C.除特殊情况外，一般不在老年人、儿童及孕妇等人群中进行D.受试者一般不应该是患有其他疾病或正在使用其他药物的患者E.不能发生超量用药情况（）68、根据我国《药品管理法实施条例》的界定，新药是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.首次在我国生产的B.未曾在中国境内上市销售的C.我国人员有参与研制的D.未曾在中国境内生产的E.未在世界上出现的（）69、饭后服用吸收更完全的头孢菌素类药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.头孢西丁B.头孢泊肟酯C.头孢羟氨苄D.头孢他啶E.头孢克洛（）70、应用后可能引起明显干咳的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.钠离子通道阻滞药B.ACE抑制药C.5-HT受体阻断药D.α受体阻断药E.钙拮抗药（）71、应用羟乙基淀粉可能造成损害的器官是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.心B.肾C.膀胱D.胃E.小肠（）72、可以让临床试验受试者的权益得到很好保障的主要措施是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.药物非临床研究管理规范B.伦理委员会和知情同意书C.药物经营质量管理规范D.标准参比制剂和试验制剂配对E.国家卫生行政管理部门的参与（）73、有关依从性的叙述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.依从性是指患者对医师医嘱的执行情况B.指患者按其家属指示的方法用药C.在我国患者服药依从性差的现象十分常见D.新药开发的目的之一可以是改善患者的依从性E.考虑患者依从性因素，才能客观评价试验结果（）74、不属于药物经济学评价方法的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.成本效用分析B.成本利润分析C.成本效益分析D.最小成本分析E.成本效果分析（）75、最能反映移植受者服用环孢素后的实际吸收情况的药动学参数是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.CB.CC.AUCD.tE.CL（）76、可用于治疗抗生素治疗中发生的难辨梭状芽孢杆菌肠炎继发感染的药物为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.红霉素B.链霉素C.去甲万古霉素D.头孢哌酮E.青霉素（）77、降糖药联合应用不合理的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.苯乙双胍+磺酰脲类B.阿卡波糖+磺酰脲类C.两种磺酰脲类联用D.长效胰岛素+短效胰岛素E.中成药+磺酰脲类（）78、儿童补液盐的处方进行了改进，新的处方中主要改进的方面是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.增加了氯化钾的量B.增加了无水葡萄糖的量C.降低了总渗透压，使在245mOsm/LD.增加了补液的渗透压E.维持了原氯化钾的量（）79、临床试验进行药品系统性研究的受试对象是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.只有病人B.只有健康志愿者C.病人或健康志愿者D.生产人员E.研究人员（）80、对于肺部给药特点的叙述不正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.吸收面积非常大B.由于肺血容量丰富，蛋白和多肽类肺部给药吸收快C.存在肝首过效应D.可提高药物的生物利用度E.由于肺泡表皮薄，药物较易透过吸收（）81、属于合理的联合用药是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.红霉素与琥乙红霉素B.美托洛尔与特布他林C.左旋多巴与苄丝肼D.交沙霉素与培菲康E.庆大霉素与链霉素（）82、感冒药康泰克被淘汰的原因是其有效成分中含有MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.对乙酰氨基酚B.去氧肾上腺素C.苯丙醇胺D.氯苯那敏E.伪麻黄碱（）83、属于不合理配伍的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.哌替啶+阿托品B.庆大霉素+红霉素C.红霉素+林可霉素D.磺胺嘧啶+甲氧苄啶E.左旋多巴+苄丝肼（）84、英文缩写"SARS"的中文全称是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.系统性红斑狼疮综合征B.急性呼吸窘迫综合征C.严重急性呼吸综合征D.消化性溃疡E.慢性支气管炎（）85、我国规定新药是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.国外已上市销售的药品B.由我国研制生产的药品C.新药是我国未生产过和从未进口过的药品D.国外已生产药品的仿制品E.新药是我国进口的药品（）86、关于药物不良反应定义的说法正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.有意的超剂量、错误用药造成的有害反应B.无意的超剂量、错误用药造成的有害反应C.正常用法、用量下出现的与治疗目的无关的有害反应D.有效成分改变的药品引起的有害反应E.出产检验不合格药品引起的有害反应（）87、复方制剂氨苄西林丙磺舒分散片中，加入丙磺舒是为了MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.促进氨苄西林的吸收B.延缓氨苄西林的代谢C.延缓氨苄西林的排泄D.扩大氨苄西林的抗菌谱E.减少氨苄西林的耐药性（）88、解救有机磷中毒时，尽早应用阿托品是为了MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.直接起解毒作用B.防止中毒过深而无法解救C.症状对抗D.使解磷定的作用更强E.保护机体的重要器官组织（）89、属于外科抗生素预防用药原则的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.任何情况下清洁手术都不得使用抗菌药物预防感染B.清洁一污染手术的预防用药时间术后6hC.清洁手术预防用药时间不超过24hD.首选广谱抗生素E.预防用药的时间需要维持到伤口愈合（）90、《中国药典》（2010年版）规定"阴凉处"是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.2～10℃B.2℃以下C.15℃以下D.不超过20℃E.室温避光（）91、配制好的肠外营养液(PN)使用完的时间不应超过MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.3hB.6hC.12hD.24hE.48h（）92、《中国药典》（2010年版）中醋酸的浓度为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.80%～90%(g/g)B.99%〔g/g〕C.40%(g/g)D.36%～37%（g/g）E.30%(g/g)（）93、在新药临床试验中，考察新药上市后疗效和不良反应（尤其是罕见不良反应）的阶段是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.Ⅰ期和Ⅱ临床试验B.Ⅱ期和Ⅲ期临床试验C.Ⅲ期临床试验D.Ⅳ期临床试验E.生物等效性评价（）94、能有效治疗肾绞痛的药物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.山莨菪碱和新斯的明合用B.阿托品和毒扁豆碱合用C.哌替啶和吗啡合用D.阿托品和哌替啶合用E.哌替啶和新斯的明合用（）95、关于普鲁卡因作用表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.为全身麻醉药B.可用于表面麻醉C.穿透力较强D.主要用于浸润麻醉E.不用于传导麻醉（）96、关于盐酸普鲁卡因的性质正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.结构中有芳伯氨基，易氧化变色B.不易水解C.本品最稳定的pH是7.0D.对紫外线和重金属稳定E.为达到最好灭菌效果，可延长灭菌时间（）97、关于盐酸利多卡因性质表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.本品对酸不稳定B.本品对碱不稳定C.本品易水解D.本品对热不稳定E.本品比盐酸普鲁卡因稳定（）98、关于巴比妥类药物理化性质表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.巴比妥类药物易溶于水B.巴比妥类药物加热易分解C.含硫巴比妥类药物有不适臭味D.巴比妥药物在空气中不稳定E.通常对酸和氧化剂不稳定（）99、对巴比妥类药物构效关系表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.R的总碳数1～2最好B.R(R)应为2～5碳链取代，或有一为苯环取代C.R以乙基取代起效快D.若R(R)为H原子，仍有活性E.1-位的氧原子被硫取代起效慢（）100、对苯巴比妥钠的表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.具有芳胺结构B.其钠盐对水稳定C.临床上用于治疗失眠、惊厥和癫痫大发作D.苯巴比妥钠在60%丙三醇水溶液中有一定的稳定性E.苯巴比妥钠水解后仍有活性（）101、对硫喷妥钠表述正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.本品系异戊巴比妥4-位氧原子被取代得到的药物B.本品系异戊巴比妥2-位氧原子被取代得到的药物C.药物的脂溶性小，不能透过血脑屏障D.本品为长效巴比妥药物E.本品不能用于抗惊厥（）102、对散剂特点叙述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.制备简单、剂量易控制B.外用覆盖面积大，但不具保护收敛功能C.贮存、运输、携带方便D.表面积大、易分散、起效快E.便于小儿服用（）103、下列不是粉碎目的的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.提高难溶性药物的溶出度和生物利用度B.有利于提高固体药物在液体中的分散度C.有助于提取药材中的有效成分D.有利于混合E.有利于药物稳定（）104、对氯丙嗪的叙述错误的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.对体温调节的影响与周围环境有关B.抑制体温调节中枢C.只使发热者体温降低D.在高温环境中使体温升高E.在低温环境中使体温降低（）105、氯丙嗪不能用于某种原因引起的呕吐，原因是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.尿毒症B.癌症C.放射病D.强心苷E.晕动病（）106、处方的结构包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.前记、正文、后记B.处方编号、药名、签名C.患者的姓名、性别、年龄、病历号等D.药品的名称、规格、数量、用法用量等E.医疗机构名称、医师签名、药学技术人员签名（）107、关于处方的叙述下列正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.处方只能由注册的执业医师开具B.处方可以由注册的执业助理医师开具C.处方可以由药学专业技术人员开具D.处方可以由注册的执业医师和执业药师开具E.处方可以由注册的执业医师和药学专业技术人员开具（）108、按照《处方管理办法》，急诊处方的颜色应为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.白色B.绿色C.淡绿色D.淡红色E.淡黄色（）109、处方的前记不包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.医疗机构名称、处方编号B.患者的姓名、性别、年龄C.药品的名称、规格、数量D.临床诊断E.科别、门诊号（）110、关于处方调配的一般程序包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.认真审核处方B.准确调配药品C.正确书写药袋或粘贴标签、包装D.向患者交付处方药品时，应当对患者进行用药说明与指导E.以上都包括（）111、调配药品时MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.需要仔细阅读处方，但不用照药品顺序逐一调配B.应同时调配多张处方，以免患者等待时间过长C.调配好的处方不需要药师签名或盖章D.需要在每种药品外包装上分别贴上用法、用量、贮存条件等的标签E.药品配齐后，为节约时间，不需要核对可直接都发给患者（）112、下列哪种药品宜单独放置MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.氯化钾注射液B.氯化钾控释片C.生理盐水D.5%葡萄糖E.以上都不是（）113、药物的物理配伍变化包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.浑浊B.沉淀C.分层D.结晶E.以上都是（）114、脂肪乳剂在与其他药物配伍时需慎重，因其易产生MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.水解B.破裂C.结晶D.变色E.浑浊（）115、在配置肠外营养液时微量元素和电解质应加入MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.脂肪乳B.水溶性维生素C.脂溶性维生素D.葡萄糖溶液E.氨基酸溶液（）116、关于配置肠外营养液注意事项的叙述不正确的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.混合顺序非常重要，在终混前氨基酸可被加到脂肪乳剂中或葡萄糖中，以保证氨基酸对乳剂的保护作用B.钙剂和磷酸盐应分别加在不同的溶液中稀释，以免发生磷酸钙沉淀C.混合液中可以加入其他药物D.现配现用，24小时输完，最多不超过48小时E.电解质不应直接加入脂肪乳剂中（）117、在配置肠外营养液时，Mg浓度应控制在MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.<1.7mmol/LB.>1.7mmol/LC.<3.4mmol/LD.>3.4mmol/LE.<5.1mmol/L（）118、药物的安全性评价必须执行MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.GCPB.GMPC.GLPD.GAPE.GOP（）119、个体化给药是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.针对患者个体的给药方案B.根据每位患者的具体情况量身订制的给药方案C.根据每位患者制定的给药方案D.针对症状制定的给药方案E.针对方方面面的情况制定的给药方案（）120、提高患者依从性需加强对患者的用药指导，以下不是用药指导的主要内容的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.治疗目的B.用法用量C.不良反应D.注意事项E.药品价格（）121、由遗传因素产生的不良反应为MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展开]MACROBUTTONDoFieldClick[替换]MACROBUTTONDoFieldClick[删除]A.B型药物不良反应B.A型药物不良反应C.D型药物不良反应D.E型药物不良反应E.C型药物不良反应（）122、阿托品用于治疗胃肠道痉挛时，引起口干、心悸、尿潴留等反应属于MACROBUTTONDoFie